Atrinsic (PTIX) Competitors $4.29 +0.05 (+1.18%) Closing price 04:00 PM EasternExtended Trading$4.28 -0.01 (-0.35%) As of 04:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock PTIX vs. ALBT, VIVS, MTNB, EPIX, ADXN, IMCC, CYCN, GNPX, BFRI, and ERNAShould you be buying Atrinsic stock or one of its competitors? The main competitors of Atrinsic include Avalon GloboCare (ALBT), VivoSim Labs (VIVS), Matinas Biopharma (MTNB), ESSA Pharma (EPIX), Addex Therapeutics (ADXN), IM Cannabis (IMCC), Cyclerion Therapeutics (CYCN), Genprex (GNPX), Biofrontera (BFRI), and Ernexa Therapeutics (ERNA). These companies are all part of the "pharmaceutical products" industry. Atrinsic vs. Its Competitors Avalon GloboCare VivoSim Labs Matinas Biopharma ESSA Pharma Addex Therapeutics IM Cannabis Cyclerion Therapeutics Genprex Biofrontera Ernexa Therapeutics Atrinsic (NASDAQ:PTIX) and Avalon GloboCare (NASDAQ:ALBT) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, dividends, risk, profitability, institutional ownership, valuation, analyst recommendations and media sentiment. Do insiders and institutionals believe in PTIX or ALBT? 8.0% of Atrinsic shares are owned by institutional investors. Comparatively, 1.4% of Avalon GloboCare shares are owned by institutional investors. 35.0% of Atrinsic shares are owned by insiders. Comparatively, 37.3% of Avalon GloboCare shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Is PTIX or ALBT more profitable? Atrinsic has a net margin of 0.00% compared to Avalon GloboCare's net margin of -1,451.94%. Avalon GloboCare's return on equity of 0.00% beat Atrinsic's return on equity.Company Net Margins Return on Equity Return on Assets AtrinsicN/A -1,586.63% -585.65% Avalon GloboCare -1,451.94%N/A -75.12% Which has stronger earnings and valuation, PTIX or ALBT? Atrinsic has higher earnings, but lower revenue than Avalon GloboCare. Atrinsic is trading at a lower price-to-earnings ratio than Avalon GloboCare, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAtrinsicN/AN/A-$5.53M-$9.44-0.45Avalon GloboCare$1.33M7.10-$7.90M-$19.96-0.12 Which has more risk and volatility, PTIX or ALBT? Atrinsic has a beta of 0.36, suggesting that its share price is 64% less volatile than the S&P 500. Comparatively, Avalon GloboCare has a beta of 0.02, suggesting that its share price is 98% less volatile than the S&P 500. Does the media prefer PTIX or ALBT? In the previous week, Atrinsic and Atrinsic both had 1 articles in the media. Atrinsic's average media sentiment score of 1.91 equaled Avalon GloboCare'saverage media sentiment score. Company Overall Sentiment Atrinsic Very Positive Avalon GloboCare Very Positive SummaryAtrinsic and Avalon GloboCare tied by winning 5 of the 10 factors compared between the two stocks. Get Atrinsic News Delivered to You Automatically Sign up to receive the latest news and ratings for PTIX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PTIX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PTIX vs. The Competition Export to ExcelMetricAtrinsicMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.53M$3.11B$5.67B$10.37BDividend YieldN/A2.39%5.75%4.64%P/E Ratio-0.4521.3275.7526.15Price / SalesN/A454.85561.41125.53Price / CashN/A45.2537.6061.28Price / Book2.199.7412.396.36Net Income-$5.53M-$52.93M$3.29B$270.97M7 Day Performance5.93%3.88%1.27%0.36%1 Month Performance8.06%7.66%3.84%6.37%1 Year Performance-46.33%20.15%60.97%28.44% Atrinsic Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PTIXAtrinsic0.6136 of 5 stars$4.29+1.2%N/A-48.1%$2.53MN/A-0.452Positive NewsALBTAvalon GloboCare1.1807 of 5 stars$2.730.0%N/A-25.6%$10.52M$1.33M-0.145VIVSVivoSim Labs0.7417 of 5 stars$4.00+7.5%N/AN/A$10.40M$140K-0.3920Gap UpMTNBMatinas Biopharma0.1617 of 5 stars$1.96-4.9%N/AN/A$9.97MN/A-0.4030Gap DownEPIXESSA Pharma2.9389 of 5 stars$0.21-3.7%$2.00+856.9%-96.7%$9.84MN/A-0.3750Dividend AnnouncementADXNAddex Therapeutics2.8177 of 5 stars$9.24-4.4%$30.00+224.9%+0.4%$9.81M$460K-27.2230News CoveragePositive NewsUpcoming EarningsIMCCIM Cannabis0.6581 of 5 stars$1.87-3.4%N/A-20.9%$9.77M$39.44M-3.44340News CoverageGap DownCYCNCyclerion Therapeutics1.4561 of 5 stars$2.91-4.4%N/A-4.2%$9.70M$2M-3.9330Gap DownGNPXGenprex1.3324 of 5 stars$0.23-1.7%N/A-47.1%$9.70MN/A0.0020BFRIBiofrontera2.075 of 5 stars$0.97-3.6%$2.75+182.3%-22.6%$9.67M$37.32M-0.4270News CoverageERNAErnexa Therapeutics1.2132 of 5 stars$1.25+3.3%N/A-92.8%$9.58M$580K-0.1510 Related Companies and Tools Related Companies Avalon GloboCare Alternatives VivoSim Labs Alternatives Matinas Biopharma Alternatives ESSA Pharma Alternatives Addex Therapeutics Alternatives IM Cannabis Alternatives Cyclerion Therapeutics Alternatives Genprex Alternatives Biofrontera Alternatives Ernexa Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PTIX) was last updated on 9/26/2025 by MarketBeat.com Staff From Our PartnersWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredWhat The Silver Boom Could Mean For You…AI, electric vehicles, and even global central banks are quietly fueling record demand for silver. This once-o...Goldco Precious Metals | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqOn September 30, 2025, at midnight ET... a groundbreaking emergency order goes into effect, issued directly by...Altimetry | SponsoredPrepare for the “Mar-a-Lago Accord” Money ShockWhy Are Wall Street Insiders Moving Their Money to This ONE Asset? Something far more consequential for you...Stansberry Research | SponsoredThis is the “End of Tesla” as we know it…Jeff has identified five of the past seven number-one performing tech stocks — before they took off. His Tesla...Brownstone Research | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Atrinsic Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Atrinsic With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PTIX Stock Alerts